SYNDIVIA

syndivia-logo

Syndivia is a biotechnology company. Syndivia's vision is to deliver the best treatment to cancer patients by harnessing unique properties of tumour hallmarks and microenvironment.

#SimilarOrganizations #People #Financial #Website #More

SYNDIVIA

Social Links:

Industry:
Biotechnology Health Care Medical

Founded:
2014-01-01

Address:
Illkirch, Alsace, France

Country:
France

Website Url:
http://www.syndivia.com

Total Employee:
1+

Status:
Active

Email Addresses:
[email protected]

Total Funding:
3.05 M EUR

Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Euro SPF Google Tag Manager Google Analytics Content Delivery Network LetsEncrypt SSL By Default Font Awesome


Similar Organizations

not_available_image

Atugen

A biotechnology company based in Berlin, Germany.

boditech-med-logo

Boditech Med

Boditech Med is a biotechnology company based in Chuncheon.

not_available_image

Cellectis

Cellartis AB is a biotechnology company based in Sweden.

fasteris-logo

fasteris

Fasteris is a Swiss biotechnology company based in Geneva.

geneius-logo

Geneius

Geneius is a Biotechnology company.

mucosis-logo

Mucosis

Mucosis is a clinical stage Dutch biotechnology company developing mucosal vaccines.

novellus-logo

Novellus

Novellus is a biotechnology company working to develop engineered cellular medicines.

themis-bioscience-logo

Themis Bioscience

Themis Bioscience is a start-up biotechnology company.

Current Employees Featured

sergii-kolodych_image

Sergii Kolodych
Sergii Kolodych CSO @ Syndivia
CSO

sasha-koniev_image

Sasha Koniev
Sasha Koniev CEO @ Syndivia
CEO

Founder


sasha-koniev_image

Sasha Koniev

sergii-kolodych_image

Sergii Kolodych

Investors List

bpifrance_image

Bpifrance

Bpifrance investment in Venture Round - Syndivia

cap-innovest_image

Cap Innov'Est

Cap Innov'Est investment in Seed Round - Syndivia

easme_image

EASME - EU Executive Agency for SMEs

EASME - EU Executive Agency for SMEs investment in Grant - Syndivia

Official Site Inspections

http://www.syndivia.com Semrush global rank: 1.94 M Semrush visits lastest month: 11.04 K

  • Host name: 198.49.23.145
  • IP address: 198.49.23.145
  • Location: New York United States
  • Latitude: 40.7157
  • Longitude: -74
  • Metro Code: 501
  • Timezone: America/New_York
  • Postal: 10013

Loading ...

More informations about "Syndivia"

Syndivia - Crunchbase Company Profile & Funding

Organization. Syndivia . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. Syndivia is a biotechnology company based in โ€ฆSee details»

About - Syndivia

©[YEAR] Syndivia, 8 Allée Gaspard Monge, ISIS, Strasbourg, Grand Est, 67083, France [email protected] [email protected]See details»

Syndivia Overview | SignalHire Company Profile

Syndivia is a private company that has been in the industry for 10 years. The company currently specializes in the Biotechnology, Biotechnology areas. The position of the Co-Founder & CEO โ€ฆSee details»

Syndivia Company Profile 2024: Valuation, Funding & Investors

When was Syndivia founded? Syndivia was founded in 2014. Where is Syndivia headquartered? Syndivia is headquartered in Strasbourg, France. What is the size of Syndivia? Syndivia has 6 โ€ฆSee details»

Syndivia - euroquity.com

About your organization Syndivia is a biotechnology company focused on the development of next-generation targeted therapies for cancer treatment. The company unites leading experts โ€ฆSee details»

Syndivia - Funding, Financials, Valuation & Investors - Crunchbase

Syndivia is a biotechnology company based in France. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. Resources. Pricing. Resources. Log In. Organization. โ€ฆSee details»

Syndivia Company Profile - Office Locations, Competitors ... - Craft

Syndivia is a biotechnology company that develops treatment solutions to cancer patients by leveraging microenvironment and anatomical hallmarks for tumors. It provides APN technology โ€ฆSee details»

Syndivia - Products, Competitors, Financials, Employees, โ€ฆ

Syndivia focuses on the development of targeted antibody-drug conjugates (ADCs) with a drug-to-antibody ratio of 1 (DAR1) for the treatment of solid tumors. Use the CB Insights Platform to โ€ฆSee details»

SYNDIVIA Company Profile | STRASBOURG, GRAND EST, France

Find company research, competitor information, contact details & financial data for SYNDIVIA of STRASBOURG, GRAND EST. Get the latest business insights from Dun & Bradstreet.See details»

Syndivia - Overview, News & Competitors | ZoomInfo.com

Syndivia's mission is to develop new therapies for p atients with the most difficult-to-treat cancer indications. Read More. View Company Info for Free. Who is Syndivia. Headquarters. 8 Allée โ€ฆSee details»

Syndivia - Contacts, Employees, Board Members, Advisors & Alumni

Syndivia is a biotechnology company based in France. Start Free Trial . Chrome ExtensionSee details»

SYNDIVIA - VentureRadar

Syndivia is a biotechnology company that is developing a pipeline of targeted therapies for solid cancers by leveraging a specific targeting of the tumor microenvironment and anatomical โ€ฆSee details»

Syndivia - Company Profile & Staff Directory - ContactOut

Syndivia's vision is to deliver the best treatment to cancer patients by harnessing unique properties of tumour hallmarks and microenvironment. Product OverviewSee details»

Syndivia - Company Profile - Tracxn

Oct 30, 2024 Syndivia ranks 1,014th among 4451 active competitors. 1351 of its competitors are funded while 910 have exited. Overall, Syndivia and its competitors have raised over $96.5B in โ€ฆSee details»

News - Syndivia

Nov 16, 2023 News & Press Archive. STRASBOURG, France, March 10, 2020 โ€“ Syndivia, a research-driven biotechnology company focused on the development of new therapeutic โ€ฆSee details»

La médecine du futur (4/5) : Syndivia, la bête de concours qui veut ...

Syndivia, la société qu'il vient de créer à Strasbourg, est entrée en négociation avec un groupe pharmaceutique français pour un projet de co-développement d'une nouvelle thérapie.See details»

Vision - Syndivia

At Syndivia, we are dedicated to advancing treatment options for cancer patients through our innovative GeminiMabโ„ข Technology. This platform enables the creation of site-specific โ€ฆSee details»

PRESS RELEASE Syndivia In-Licenses DARx Technology for 1-to-1 โ€ฆ

* Organization for accelerating tech transfer About Syndivia Syndivia is a research-driven biotechnology company that is developing a pipeline of targeted therapies for solid cancers by โ€ฆSee details»

Pipeline - Syndivia

2017: Out-licensing agreement established with Inatherys, limited to one target (CD71). The ADC is currently undergoing phase I/IIa clinical trial (NCT03957915). 2022: Auricula Biosciences co โ€ฆSee details»

linkstock.net © 2022. All rights reserved